DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹82.68 | ₹60.38 | ₹68.83 | ₹111.53 | ₹74.75 |
What is the latest Earnings Per Share (EPS) of DIVIS LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹82.68 |
| Mar2025 | ₹60.38 |
| Mar2024 | ₹68.83 |
| Mar2023 | ₹111.53 |
| Mar2022 | ₹74.75 |
How is Earnings Per Share (EPS) of DIVIS LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹82.68 | 36.93 | |
| Mar2025 | ₹60.38 | -12.28 | |
| Mar2024 | ₹68.83 | -38.29 | |
| Mar2023 | ₹111.53 | 49.20 | |
| Mar2022 | ₹74.75 | - | |
Compare Earnings Per Share (EPS) of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹213,904.1 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| MANKIND PHARMA | ₹102,006.0 Cr | -3.2% | -0.7% | -0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 8.6% |
20.7% |
18.5% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses